EP3897654
TREATMENT OF HYPERCOAGULOPATHY IN CUSHING'S SYNDROME BY ADMINISTRATION OF A GLUCOCORTICOID RECEPTOR MODULATOR
:
EP einkaleyfi: Þýðing ekki lögð inn:
20.12.2019:
15.1.2025:
19898016.1
:
19.12.2039
:
TREATMENT OF HYPERCOAGULOPATHY IN CUSHING'S SYNDROME BY ADMINISTRATION OF A GLUCOCORTICOID RECEPTOR MODULATOR
20.12.2019
15.1.2025
:
Corcept Therapeutics Incorporated:
101 Redwood Shores Parkway, Redwood City, CA 94065, US
:
MORAITIS, Andreas G.:
Menlo Park, California 94025, US
:
201862784270 P:
21.12.2018:
US
:
US2019067894:
20.12.2019
:
A61K 31/567, A61K 31/4745, A61K 45/06, A61P 7/00, A61P 7/02, G01N 33/86